Exosomal Transfer of Macrophage-Derived miR-223 Confers Doxorubicin Resistance in Gastric Cancer.
Huijie GaoJincheng MaYanhui ChengPeiming ZhengPublished in: OncoTargets and therapy (2020)
The exosomal transfer of macrophage-derived miR-223 conferred doxorubicin resistance in GC and targeting exosome communication may be a promising new therapeutic strategy for GC patients.